Bimervax, HIPRA’s COVID-19 vaccine, has received pan-EU marketing authorization for use as a booster in people aged 16 years and above who have been vaccinated with an mRNA COVID-19 vaccine.
Bimervax (COVID-19 Vaccine (recombinant, adjuvanted)) is the eighth COVID-19 vaccine to be approved in the EU. It was recommended for...








